Skip to main content
. 2018 Jun 24;2018:1374821. doi: 10.1155/2018/1374821

Figure 4.

Figure 4

Percentage of patients with amenorrhoea at the end of each treatment interval with 5 mg of UPA (PP4; PEARL IV).